B
rachial pulse pressure (PP), defined by the difference between systolic and diastolic blood pressure (BP), is a well-known independent cardiovascular risk factor, particularly for myocardial infarction in patients Ͼ50 years of age, whether they are normotensives or hypertensives, or with a history of cardiovascular disease. 1 Brachial PP may be also considered as an indirect marker of aortic stiffness, which is itself an independent predictor of cardiovascular risk. [2] [3] [4] [5] However, studies of pulsatile arterial hemodynamics have shown that, whereas mean arterial pressure remains nearly constant along the arterial tree, PP increases markedly from central (thoracic aorta and carotid artery) to peripheral (brachial) arteries. This increase is due to the propagation of the pressure wave along arterial vessels with a progressive decline in artery diameter and an increase in arterial stiffness resulting in a modification in the timing of wave reflection and thus leading physiologically to PP amplification. 6 Aortic PP is, therefore, expected to be more relevant to investigate cardiovascular risk than brachial PP, being closer to the heart, coronary arteries, and carotid arteries, the sites of occurrence of major cardiovascular events. Recently, there has been more emphasis on aortic rather than peripheral PP to predict cardiovascular risk. 7 Aortic pulsatility, but not brachial pulsatility, has been shown to be independently associated to the presence of coronary artery disease in patients undergoing coronary angiography, 8 and also to predict the incidence of restenosis after balloon angioplasty. 9 However, no relationship was established between the level of aortic PP and the extent of coronary artery disease (CAD), and between the level of aortic PP and in-stent restenosis.
In this study, we investigated patients who underwent percutaneous transluminal coronary angioplasty (PTCA) as a result of acute myocardial infarction to establish whether aortic or brachial PP were related to the extent of coronary alteration, as judged on the coronary angiography. We also investigated the association between aortic BP and restenosis after coronary angioplasty in the stent era.
Methods

Patients
From September 1999 to September 2000, approximately 1000 patients entered the department of cardiac catheterization at the Institut Mutualiste Montsouris (Paris, France) for a coronary angiography ordered by their cardiologist for indications including, not only ischemic chest pain but also other cardiovascular disorders such as acute or convalescent myocardial infarction. From those patients, 420 underwent PTCA. We excluded patients with acute myocardial infarction, and patients with hemodynamically significant valvular heart disease as assessed during cardiac catheterization. Subjects who had no available aortic pressure measurement at baseline (before angiography was performed) were also excluded from the study. Thus, the study cohort was composed of 99 consecutive patients (81 men, 18 women) with mean age (Ϯ SD) of 65 Ϯ 11 years. Thirty percent of patients were current smokers, 59% of them had dyslipidemia (definition to follow) (44% treated by a statin and 7% treated by a fibrate), 19% had type 2 diabetes mellitus (definition to follow), 59% were taking ␤-blockers, 35% angiotensin converting enzyme inhibitors, 19% diuretics, 46% calcium channel blockers, 77% aspirin, 20% ticlopidin or clopidogrel, and 40% nitrates or molsidomine at admission.
Thirty-seven percent of the study population had a past history of myocardial infarction, 55% of patients had a past history of unstable angina, and 42% a past history of stable angina (definitions to follow). Before the present study, 9% had a history of congestive heart failure, 15% of recruited patients had a history of coronary aortic bypass grafting (CABG), and 23% a history of PTCA. Ten percent reported other atherosclerotic alterations including stroke, peripheral vascular disease, and abdominal aortic aneurysm. For patients who had more than one catheterization during the study period, only information available at the first procedure was considered.
Data Collection
Clinical and hemodynamic information was collected from the cardiac catheterization laboratory register of procedures and from patient medical records. It included gender, age, weight, height, body mass index, personal history of dyslipidemia as currently defined, 10 or the presence of lipid-lowering therapy, smoking, and presence of type 2 diabetes mellitus defined as a fasting blood glucose of 7.0 mmol/L or more or the use of an antidiabetic medication. Clinical characteristics of the overall population is indicated in Table 1 . Stable angina pectoris was associated to unstable angina pectoris or myocardial infarction in 25 patients. 11 All subjects gave informed consent for this study and study protocol was approved by our local Institutional Review Board.
Resting brachial systolic BP (SBP) and diastolic BP (DBP) were measured on the day of catheterization by trained nurses using a sphygmomanometer. Phases I and V of Korotkoff sounds were used for SBP and DBP, respectively. Invasive intraaortic SBP and DBP were measured using a fluid-filled 4F catheter at baseline before any injection of contrast material. Mean aortic BP was obtained by direct integration of the BP curve. Aortic PP was calculated as the difference between aortic SBP and DBP. Aortic pulsatility was defined as the ratio of PP to mean pressure. We used the mean values of 10 BP curves measurements for each component. Heart rate was recorded using electrocardiographic monitoring. Left ventricle ejection fraction was computed by angiography. The three major coronary vessels were considered to evaluate the extent of the large artery stenotic alterations: the left anterior descending artery, the circumflex artery, and the right coronary artery. A diseased vessel was defined as having Ͼ50% stenosis on at least one of its segments. 12 Forty-one patients had one-vessel disease, 32 patients had two-vessel disease, and 26 patients had three-vessel disease. Angioplasty was performed on one vessel in 76 patients, two vessels in 17 patients, and three vessels in 6 patients. Restenosis after PTCA was defined as the relapse of more than 50% stenosis at the site of the considered procedure.
Analysis
Data are expressed as mean Ϯ SD for quantitative variables and percentages for discrete variables. Present or absent risk factors or diseases are expressed as dummy variables (0 if absent and 1 if present). Gender is also expressed as a dummy variable (0 for men and 1 for women). Analysis of variance (ANOVA) and Student t test were used for comparison of normally distributed continuous variables. Differences in frequency (cross-tabulated discrete variables) were tested using 2 test. Statistical analysis was performed using NCSS 6.0.21 software (Jenny L. Hintze, Cork, Ireland). Repeatability and reproducibility of the methods were defined as recommended by the British Standard Institution. 13 A value of P Ͻ .05 was considered significant. All testing was double-sided. Multiple regression analysis was used to assess clinical and hemodynamic determinants of the number of diseased vessels. We used a stepwise regression and forced classic cardiovascular risk factors.
After an average follow-up of 1 year, patients were divided into two groups according to the presence or absence of clinical restenosis. Factors associated with restenosis were assessed in an univariate analysis using Student t test and were used for comparison of normally distributed continuous variables between both groups and 2 test for differences in frequency (cross-tabulated discrete variables).
Finally, a stepwise multiple regression was used to assess clinical variables associated with aortic PP.
Results
Clinical characteristics and classic cardiovascular risk factors in relation to the number of diseased coronary vessels are shown in Table 1 . Medications are shown in Table 2 . and hemodynamic parameters are shown in Table 3 . Globally, in univariate analysis, classic cardiovascular risk factors (age, gender, smoking, diabetes mellitus, dyslipidemia, body mass index, renal insufficiency, brachial BP, and previous cardiovascular disease) were not associated to an increase in the number of diseased vessels, except for an association to the presence of lipid disorders of borderline significance (P ϭ .07) ( Table 1) . Medications, especially nitrates, were not associated with the number of diseased vessels except for an increasing use of calcium channel blockers (P ϭ .049) ( Table 2 ). Invasive aortic, but not noninvasive brachial, systolic, mean, and PP were significantly associated to an increase in the number of diseased vessels (Table 3) . In multiple regression analysis, only male gender and the level of aortic PP were independently associated with the extent of CAD (P ϭ .013 and P ϭ .023, respectively). R 2 for the model was 0.24 (Table 4) . Using stepwise multiple linear regression with aortic PP as dependent variable, age, higher mean aortic pressure, female gender, number of diseased vessels, and lower heart rate were significantly and independently associated to higher aortic PP (Table 5) . Overall, those factors explained 57% of aortic PP variance. A multivariate model involving aortic pulsatility as a dependent variable lead to similar associations (data not shown).
Of the 99 patients studied, 3 had an ineffective angioplasty at the day of the considered procedure (total chronic occlusion). Among the 96 remaining patients, a stent was implanted in 87 patients (90%) and 11 patients had an angiographically documented restenosis (11%). Restenosis was discovered between 23 and 503 days after the procedure (median, 101 days). Of the 11 subjects with restenosis, 2 did not have a stent implantation on the day of angioplasty. All subjects were treated during the procedure and took an antiplatelet combination of aspirin and clopidogrel for 1 month. There was no acute stent thrombosis. Comparison of patients with restenosis (n ϭ 11) to patients without restenosis (n ϭ 85) showed a borderline significant association of restenosis to aortic mean BP (P ϭ .05) and to a history of multiple previous PTCA (P ϭ .03). These associations were observed after adjustment on age and gender. Restenosis had no significant association with central or peripheral PP.
Discussion
The present study has shown for the first time an association between a high aortic PP and the extent of CAD in patients who underwent PTCA. No significant association was observed between aortic or brachial PP and restenosis after angioplasty. Sphygmomanometer-measured brachial BP has many limitations; DBP measured by this method is substantially less accurate than SBP, compared to invasive measurements.
14 Therefore, intraaortic PP measured invasively during cardiac catheterization should be a better index of aortic stiffness than brachial PP. In addition it is closer to the heart, coronary vessels, and carotid arteries and it allows an accurate measurement of mean arterial pressure by direct integration of BP curve.
Previous studies 12, 15, 16 have shown a significant association between CAD and reduced aortic or carotid compliance. Because, in most of them, brachial, but not aortic, BP are measured 14 and because brachial PP is significantly higher than aortic PP for the same mean arterial pressure, 6 these studies did not show that aortic PP, and not aortic stiffness, was the main parameter significantly associated with the presence of CAD. Using invasive procedures, Nakayama et al 9 were the first to show a close association between aortic PP and the presence of CAD qualitatively evaluated. To our knowledge, the present study is the first to relate an independent and significant association between aortic PP, a robust parameter poorly sensitive to placebo, 17 and the extent of CAD quantitatively assessed from the number of diseased coronary vessels. A similar finding may be observed using carotid PP instead of aortic PP as an index of central BP. 18 Our group recently reported that, in a population of 180 end-stage renal disease patients, carotid but not peripheral PP was an independent predictor of all-cause (including cardiovascular) mortality. 7 Nakayama et al 9 investigated 53 patients with stable angina pectoris or silent myocardial ischemia who underwent coronary angiography 3 months after PTCA. They found an independent association between restenosis after PTCA and pulsatility of the ascending aorta (pulsatile to mean aortic pressure). It should be mentioned that these patients were investigated between January 1993 and December 1998, and, at this period, underwent balloon angioplasty without stent. They found a high rate of restenosis (43%) 3 months after angioplasty.
In our study, 91% of patients with PTCA had stent implantation and we found a relatively low proportion of restenosis (11%) after an average of 1 year of follow-up, consistent with results of recently published clinical trials with similar durations of follow-up. 19 Surprisingly, in our study using stents, we found no association between brachial or aortic PP and restenosis, and only a weak association to aortic mean pressure. It should be noted that stent can mechanically protect the artery wall from pulsatile forces, and, on the other hand, stent implantation has recently been shown to increase the expression of matrix metalloproteinases. 20 Further prospective studies are needed to investigate the relationship between stent and pulsatility for the risk of restenosis.
Aging changes in PP or arterial stiffness have been suggested to be possibly modulated by different gene polymorphisms. 21 However, aging can modify the elastic properties per se by an increase in the ratio of collagen type I to III, 22 by accumulating advanced glycation end products on both elastin and collagen fibers, 23 or by fragmentation of the elastic lamellae induced by the cumulative fatiguing cyclic stress. 6 In recent years, PP has been shown to be a significant and independent predictor of CAD.
1 It has been suggested that this finding was due to two factors: an increase in oxygen demand, related to the increase in SBP and the resulting increase in cardiac mass; and a reduction in oxygen supply, related to the decrease in DBP and the resulting decrease in coronary perfusion. The present study clearly indicates for the first time that structural alterations of the coronary arterial wall are also directly and quantitatively involved. Further studies are needed to explore this potential cause-effect relationship. CAD ϭ coronary artery disease; other abbreviation as in Tables 3 and 4 . Dependent variable: aortic pulse pressure (r 2 ϭ 0.57; P Ͻ .0001).
